World Ovarian Cancer Day, observed annually on 8 May, is a global initiative to raise awareness, share knowledge, and inspire action in the fight against ovarian cancer. World Ovarian Cancer Day reminds us that every woman, no matter where she lives or what her circumstances are, deserves access to the knowledge, resources, and care that could save her life. Awareness saves lives. Early detection and timely treatment make a difference. To mark this important day, we are proud to present a curated collection of articles and Special Issues, dedicated to groundbreaking research and innovative approaches in ovarian cancer. We invite readers to explore these contributions and join us in supporting the global fight against ovarian cancer.

“The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities”
by Bianca Garlisi, Sylvia Lauks, Caroline Aitken, Leslie M. Ogilvie, Cielle Lockington, Duncan Petrik, Jan Soeren Eichhorn and Jim Petrik
Curr. Oncol. 2024, 31(7), 3826-3844; https://doi.org/10.3390/curroncol31070283

“Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox”
by Sara Moufarrij and Roisin E. O’Cearbhaill
Curr. Oncol. 2024, 31(1), 97-114; https://doi.org/10.3390/curroncol31010007

“Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs”
by Ramlogan Sowamber, Alexandra Lukey, David Huntsman and Gillian Hanley
Curr. Oncol. 2023, 30(12), 10179-10194; https://doi.org/10.3390/curroncol30120741

“Beyond Sterilization: A Comprehensive Review on the Safety and Efficacy of Opportunistic Salpingectomy as a Preventative Strategy for Ovarian Cancer”
by Tahereh Zadabedini Masouleh, Holly Etchegary, Kathleen Hodgkinson, Brenda J. Wilson and Lesa Dawson
Curr. Oncol. 2023, 30(12), 10152-10165; https://doi.org/10.3390/curroncol30120739

“Dysregulation of Cholesterol Homeostasis in Ovarian Cancer”
by Zahraa Qusairy, Anne Gangloff and Shuk On Annie Leung
Curr. Oncol. 2023, 30(9), 8386-8400; https://doi.org/10.3390/curroncol30090609

“Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review”
by Caitlin Lazurko, Revital Linder, Kate Pulman, Genevieve Lennox, Tomer Feigenberg, Rouhi Fazelzad, Taymaa May and Tiffany Zigras
Curr. Oncol. 2023, 30(9), 8159-8171; https://doi.org/10.3390/curroncol30090592

“Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer”
by Paraskevi Detopoulou, George I. Panoutsopoulos, Marina Mantoglou, Periklis Michailidis, Ifigenia Pantazi, Spyros Papadopoulos and Andrea Paola Rojas Gil
Curr. Oncol. 2023, 30(3), 3391-3420; https://doi.org/10.3390/curroncol30030258 

“A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer”
by Huiling Xiang, Fan Yang, Xiaojing Zheng, Baoyue Pan, Mingxiu Ju, Shijie Xu and Min Zheng
Curr. Oncol. 2023, 30(3), 3289-3300; https://doi.org/10.3390/curroncol30030250

“Stratification of Length of Stay Prediction following Surgical Cytoreduction in Advanced High-Grade Serous Ovarian Cancer Patients Using Artificial Intelligence; the Leeds L-AI-OS Score”
by Alexandros Laios, Daniel Lucas Dantas De Freitas, Gwendolyn Saalmink, Yong Sheng Tan, Racheal Johnson, Albina Zubayraeva, Sarika Munot, Richard Hutson, Amudha Thangavelu, Tim Broadhead et al.
Curr. Oncol. 2022, 29(12), 9088-9104; https://doi.org/10.3390/curroncol29120711

“Safety Profile of Niraparib as Maintenance Therapy for Ovarian Cancer: A Systematic Review and Meta-Analysis”
by Antonia Pagkali, Ioannis Mamais, Adamantios Michalinos and Aris P. Agouridis
Curr. Oncol. 2022, 29(1), 321-336; https://doi.org/10.3390/curroncol29010029

“Clinical Advances and Progress in the Treatment of Gynecological Cancers”	“Ovarian Cancer in the Age of Precision Medicine”